xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.23262, Wiley Online Library on [02/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

198

KUANetal.

TABLE XXI.B.2 Evidence for preoperative imaging in distinguishing IP-SCC from IP.

Clinical endpoints

Study

Year LOE Study design Study groups

Conclusion

Suhet al. 1126

IP: 1. 85% demonstrated CCP, 10% with partial loss, 5% with complete loss. 2. 34% demonstrated bone erosion onCT. IPSCC 1. 5% demonstrated CCP, 48% with partial loss, 48% with complete loss. 2. 91% demonstrated bone erosion onCT. 3. Mean ADC is lower in IP-SCC (1.20 vs. 1.51, p < 0.001) 4. Conventional imaging features (CT, MRI) with ADC values can predict IP-SCC IP: 1. 60% demonstrated CCP, 26.7% with partial loss, 13.3% with complete loss. 2. 28.2% demonstrated bone erosion on CT. IP-SCC: 1. 17.1% demonstrated CCP, 22.9% with partial loss, 60% with complete loss. 2. 74.2% demonstrated bone erosion on CT. 3. Mean ADC is lower in IP-SCC (1.12 vs. 1.49, p = 0.002) IP-SCC is associated with bone destruction on CT ( p < 0.001) 1. CCP is detected at a high rate in IPs 2. All IPs and IP-SCCs demonstrated CCP 3. Only five DN-SCCs (15.2%) demonstrated CCP Note: study did not subcategorize partial or complete loss of CCP 1. All IPs demonstrated diffuse CCP 2. Half (50%) of IP-SCCs demonstrated diffuse CCP, with the other half with partial or focal loss of CCP 3. Partial CCP can be indicative of IP-SCC (Continues)

1. Loss of CCP 2. Bone Erosion 3. ADC

2021

4

Retrospective case series

Biopsy-proven IP ( n = 41), IP-SCC ( n = 21)

Yanet al. 1124

2019 4

Retrospective case series

Biopsy-proven IP

1. Loss of CCP 2. Bone Erosion 3. ADC

( n = 30), IP-SCC ( n = 35)

Miyazaki et al. 1120

Bone destruction onCT

2018 4

Retrospective case series

Biopsy-proven IP

( n = 64), IP-SCC ( n = 6)

Fujima et al. 1125

2015 4

Retrospective case series

Biopsy-proven IP

Loss ofCCP

( n = 5), IP-SCC ( n = 3),DN-SCC ( n = 33)

Jeonet al. 1123

Loss ofCPP

2008 4

Retrospective case series

Biopsy-proven IP ( n = 22), IP-SCC ( n = 8)